Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Olfactory receptor family 2 subfamily AE member 1 (OR2AE1) is a protein in humans encoded by the OR2AE1 gene[1][3][8]. Like other olfactory receptors, it is expressed in the olfactory epithelium where it binds odorant molecules in the nose, initiating a signaling cascade via G protein-mediated transduction that ultimately triggers neuronal responses and gives rise to odor perception[1][3][7][8][9]. OR2AE1 is a typical class A (rhodopsin-like) GPCR with a seven-transmembrane domain architecture. Olfactory receptors as a group constitute the largest gene family in the human genome. There is currently no known involvement of OR2AE1 in human disease nor evidence that it is targeted by approved drugs or used as a biomarker[1][3][9]. Its primary and specific biological function is in sensory signaling for olfaction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Olfactory receptor family 2 subfamily AE member 1 (OR2AE1).